treatment response assessment in melanoma and the challenge of pseudoprogression with immunotherapy
Published 7 years ago • 407 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
3:58
time to response to immunotherapy and the concept of pseudoprogression
-
1:24
acquired resistance: facing the challenge of immunotherapy in patients with lung cancer
-
10:35
measuring response to immunotherapy in melanoma
-
4:29
abscopal effect and pseudoprogression in melanoma
-
2:32
current status of immunotherapy for advanced melanoma
-
4:27
key updates in immunotherapies for melanoma
-
1:48
influence of new immunotherapy checkpoint inhibitors in melanoma
-
3:05
immunotherapy cancer treatment: what is pseudoprogression?
-
6:42
pseudoprogression with checkpoint inhibitors in non-small cell lung cancer
-
7:38
pseudoprogression on immunotherapy in hnscc
-
2:14
how imaging techniques used to assess response in skin cancer are changing
-
2:29
overcoming resistance to immunotherapy
-
6:57
keynote-177 discussion: chemo-immunotherapy, pseudoprogression & biomarkers
-
1:45
mechanisms of resistance to checkpoint inhibitors in melanoma
-
2:01
case study: pseudoprogression in urothelial cancer
-
2:22
immunotherapy toxicities and checkpoint inhibitor therapy
-
3:36
measuring response with immuno-oncology agents in nsclc
-
6:03
immunotherapy: toxicity, pseudo-progression, and varied responses
-
4:57
pseudoprogression on immunotherapy in squamous nsclc